UPMC Personalizes Medications for Heart Patients Through Innovative Gene Testing

02/10/2016 | UPMC Health Plan
Patients who go to UPMC Presbyterian for heart catheterization and who receive a stent to treat clogged arteries are now being screened with a simple blood test to determine if they have a gene variant that makes them less likely to respond to a blood-thinning medication commonly prescribed after the procedure. The program aims to use clinical pharmacogenomics knowledge to individualize patient treatments – part of a broader program at UPMC that could eventually include a wide variety of drugs to improve outcomes for patients.